Navigation Links
Rheumatoid Arthritis Rising Among U.S. Women
Date:10/27/2008

Cases have increased since the mid-1990s, study shows

MONDAY, Oct. 27 (HealthDay News) -- The number of American women with rheumatoid arthritis (RA) is growing again after four decades of decline, according to a Mayo Clinic study.

The researchers tracked 350 adult patients, averaging 56.5 years of age, from Olmsted County, Minn. Of those patients, 69 percent were women.

In the United States, the incidence of RA had steadily declined from 1955 to 1994. But that changed in the mid-1990s, the study found. The Mayo researchers' analysis of data from early 1995 to the start of 2005 revealed that both the incidence and prevalence of RA were rising.

During those 10 years, the incidence of RA among women increased to 54 per 100,000, compared to 36 per 100,000 in the previous 10 years. The incidence of RA among men remained at about 29 per 100,000.

The rate of RA in the overall population increased from 0.85 percent to 0.95 percent.

The reason for the increase isn't clear, but environmental factors may play a role in the rise of the joint disease among women, the researchers suggested.

The study was to be presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, in San Francisco.

More information

The Arthritis Foundation has more about rheumatoid arthritis.



-- Robert Preidt



SOURCE: Mayo Clinic, news release, Oct. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
2. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
3. New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment Through Generations
4. FDA Advisory Committee Recommends Approval of ACTEMRA(R) (tocilizumab) for the Treatment of Rheumatoid Arthritis
5. New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment through "Generations"
6. High Birth Weight Doubles Risk of Rheumatoid Arthritis
7. Heavy birthweight increases risk of developing rheumatoid arthritis
8. Heavy birthweight babies twice as likely to develop rheumatoid arthritis
9. Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
10. Rheumatoid Arthritis Treatment Guidelines Updated
11. Rheumatoid Arthritis Drug Boosts Melanoma Incidence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rheumatoid Arthritis Rising Among U.S. Women
(Date:3/30/2017)... DC (PRWEB) , ... March 30, 2017 , ... ... and organizations submitted a letter to President Trump expressing their support for an ... medical doctors, two Ph.D. scientists and one medical journalist, will hold a press ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, ... each year develop other types of metastatic brain tumors(3). Though most meningiomas are benign, ... efforts focus on finding more effective treatment options, the San Diego Gamma Knife ...
(Date:3/29/2017)... ... ... the main cause of hay fever in the United States, with an estimated 95 percent ... to July each year; with the worst time for sufferers being June and July. ... ) provide an effective defense against grass pollen; they are proven in independent studies to ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, are ... it has been used for thousands of years. , "The West has caught on, ... " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of the ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, ... Stores in two southeastern states. Ingredients in HeartBoost, an over the counter heart ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... PHILADELPHIA , March 30, 2017  Lannett Company, ... the company voluntarily made a $25 million payment against ... $25 million payment, combined with the $75 million payment ... us approximately $5.5 million in annualized cash interest expense, ... executive officer of Lannett.  "Our business is solid and ...
(Date:3/30/2017)... Research and Markets has announced the ... & Forecast, By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, ... 2014 To 2025" report to their offering. ... The global ... 108.5 billion by 2025. Home-based dialysis ...
(Date:3/29/2017)... 29, 2017  Bodycad announced today that it ... 510(k) clearance for its Bodycad Unicompartmental Knee System, ... orthopaedic restoration. Bodycad is the first Canadian company ... implant system. Bodycad,s revolutionary Unicompartmental ... of the patient,s unique anatomical features and kinematics. ...
Breaking Medicine Technology: